"Purity" is the first number most researchers look at on a peptide Certificate of Analysis (COA) — but the percentage printed there is not a direct measurement of how much peptide, by mass, is actually inside the vial. We've already covered how to read a COA end-to-end in how to read a Certificate of Analysis, and how HPLC and mass spectrometry answer different questions in HPLC vs. mass spectrometry. This article goes one level deeper into a single figure: exactly how peptide purity percentage is calculated from HPLC peak-area data, what is and isn't counted in that number, and why a vial labeled 99% pure can still vary meaningfully in usable peptide mass from another vial carrying the identical label.
How the Purity Percentage on a COA Is Actually Calculated
Peptide purity percentage is almost universally derived using the area normalization method in reversed-phase HPLC. A sample is dissolved and injected onto a column, where components separate based on their interaction with the stationary phase and elute at different retention times. A UV detector — typically set near 210–220 nm, where the peptide bond itself absorbs — records a continuous signal as each component passes through, and integration software calculates the area under every resolved peak on the resulting chromatogram.
The purity figure is then: (area of the target peptide peak ÷ total area of all integrated peaks) × 100. If the main peak accounts for 99,100 of 100,000 total integrated area units, the reported purity is 99.1%. This is a relative measurement of UV-absorbing material under a specific set of chromatographic conditions — not an absolute measurement of how many milligrams of peptide are physically present in the vial. That distinction is the source of nearly every purity-related misunderstanding downstream, and it's worth sitting with before moving to what actually shows up in that denominator.
What Counts Against the Purity Number: Related Substances
Every peak on the chromatogram other than the target peak is grouped, collectively, into what analytical chemists call "related substances." For a synthetic peptide, these typically include:
- Deletion and truncated sequences — peptides missing one or more residues due to incomplete coupling during solid-phase synthesis
- Deamidated variants — asparagine or glutamine side chains that have converted to aspartate or glutamate, often a slow degradation pathway during storage or handling
- Oxidized variants — methionine, cysteine, or tryptophan residues that have picked up an oxygen atom, shifting both mass and chromatographic retention
- Diastereomers — residues that racemized during synthesis, producing a peptide with the correct sequence but the wrong stereochemistry at one position
- Aggregates and residual synthesis byproducts — dimers, coupling reagent residues, and protecting-group fragments left over from the manufacturing process
Each of these elutes as its own peak, and each contributes to the denominator of the purity calculation. A tighter cluster of related-substance peaks with smaller combined area produces a higher purity number; a broader spread of degradation and synthesis byproducts pulls it down. Critically, this entire calculation only accounts for compounds that absorb UV light at the detection wavelength used. Anything that doesn't — including the substances discussed next — never appears on the chromatogram at all, and therefore never factors into the purity percentage in either direction.
Why 99% Pure Doesn't Mean 99% Peptide by Mass
This is the gap between two figures that get conflated constantly: HPLC purity and net peptide content. Purity describes the composition of the UV-absorbing signal — what fraction of detected peaks is the target peptide versus related substances. Net peptide content describes what fraction of the vial's total physical mass is actually peptide, versus everything else that doesn't show up in a purity chromatogram at all.
Synthetic peptides purified by preparative HPLC are typically isolated using trifluoroacetic acid (TFA) in the mobile phase, and TFA readily forms an ion pair with basic residues (arginine, lysine, histidine) in the peptide, remaining bound as a counterion after lyophilization. Some manufacturers perform a salt-exchange step to swap TFA for acetate, which is generally considered gentler for downstream research applications, but either counterion still contributes real mass to the lyophilized powder without ever eluting as a separate peak in the purity method. Residual moisture is the second major contributor — lyophilized peptides are hygroscopic, and water content absorbed during processing or storage adds mass that is chemically inert to the purity assay but very real on a balance.
Because neither counterion mass nor moisture content shows up in a UV chromatogram the way a peptide-related impurity does, an HPLC purity method has no way to detect or report them. Net peptide content is instead determined through separate analytical methods — commonly amino acid analysis or nitrogen determination — that measure the peptide backbone directly rather than inferring it from chromatographic peak area.
Two Vials, Same 99% Purity Label, Different Net Peptide Content
Consider two lots that both report 99% HPLC purity. A BPC-157 vial synthesized with a lower TFA counterion load and minimal residual moisture might carry a net peptide content around 90–95% of total mass. An Epitalon vial — a much shorter sequence with a different residue composition and salt-binding profile — could report the same 99% HPLC purity yet carry a meaningfully different net peptide content once counterion and moisture mass are accounted for. Sequence length, residue composition (more basic residues generally means more TFA-binding sites), and lyophilization/storage handling all independently affect that second number, and none of them move the purity percentage at all.
The same logic applies across compound classes. A NAD+ vial and a Tesamorelin vial can each carry a COA reporting 99% purity while differing by a double-digit percentage in actual peptide-equivalent mass, simply because the non-peptide fraction of each — water, counterion, residual solvent — is a function of that specific molecule's chemistry and that specific lot's processing, not of the purity method used to test it. Two vials with identical purity labels are not guaranteed to deliver identical molar peptide quantities when reconstituted to the same nominal concentration.
Why This Gap Matters for Reproducibility in Comparative Research
For any research design that compares results across batches, time points, or suppliers, treating "purity percentage" as a stand-in for material equivalence introduces a hidden variable. Two batches carrying the same 99% purity claim can still differ in net peptide content by ten percentage points or more, which means solutions prepared to the same nominal concentration from each batch may not contain the same actual molar quantity of peptide. In a comparative or dose-response design, that gap is indistinguishable from a real experimental effect unless it's accounted for at the material-characterization stage — which is precisely the kind of confound that undermines reproducibility between labs, or even between two runs in the same lab using different lots.
This is why net peptide content, when available, belongs in a lab's material records alongside HPLC purity and lot number — not as a replacement for purity, but as the complementary figure that lets a solution's actual peptide concentration be characterized rather than assumed from label claims alone. Documenting both numbers is a small addition to an intake workflow that pays off directly the first time a result needs to be traced back to a specific batch.
What We Disclose Beyond the Purity Number
Most suppliers stop at HPLC purity because it's the easier number to generate and the one buyers ask for by default. Our lab reports both figures — HPLC purity and net peptide content — on the third-party Certificates of Analysis we publish for the compounds we carry, rather than purity alone. We view that as a meaningful differentiator: a purity number by itself tells a researcher how clean the chromatographic profile looks, but it doesn't tell them how much of the vial is actually peptide. Publishing both is what lets researchers sourcing from our catalog characterize material accurately rather than inferring net content indirectly, or not at all.
Where This Fits With the Rest of Your QC Review
Purity percentage answers one specific question: how clean is the chromatographic profile relative to related substances. It doesn't answer whether the peak is the correct molecule — that's what mass spectrometry confirms, as covered in HPLC vs. mass spectrometry — and it doesn't answer how much of the vial's mass is peptide at all, which is the net content question addressed here. Reading a COA well means holding all of these pieces at once rather than anchoring on a single headline percentage; our broader walkthrough in how to read a Certificate of Analysis covers the rest of the document. For guidance on evaluating whether a supplier's documentation practices meet this standard in the first place, see how researchers vet a peptide supplier, and for how material characterization fits into broader experimental design, see designing reproducible peptide studies.
Frequently Asked Questions About Peptide Purity Percentage
What does peptide purity percentage actually measure?
It measures the proportion of UV-detected signal on an HPLC chromatogram attributable to the target peptide peak, relative to the total area of all detected peaks, including related substances such as deletion sequences, deamidated or oxidized variants, and synthesis byproducts.
Why can two peptides both labeled 99% pure differ in actual peptide mass?
Because HPLC purity doesn't detect non-UV-absorbing material like water content or counterions (TFA or acetate salts) bound to the peptide. Two lots with identical purity percentages can carry different amounts of that non-peptide mass, producing different net peptide content despite the same purity label.
How is net peptide content different from HPLC purity?
HPLC purity is a chromatographic measurement of signal composition. Net peptide content is a mass-based measurement of how much of the vial's total physical mass is actual peptide, typically determined by amino acid analysis or nitrogen determination rather than the HPLC purity method itself.
Why does the purity-versus-net-content distinction matter for research reproducibility?
Because solutions prepared to the same nominal concentration from two batches with matching purity labels but different net peptide content will not contain the same actual molar quantity of peptide — a hidden variable that can confound comparative or dose-response results across batches, time points, or suppliers.
Cited Research Literature
- Wang W, Singh SK, Li N, Toler MR, King KR, Nema S. Factors affecting the physical stability (aggregation) of peptide therapeutics. PubMed PMID 29147559
- Muttenthaler M, et al. Trends in peptide drug discovery. Nature Reviews Drug Discovery. PubMed PMID 33536635
Explore Our Research Catalog
Every compound in our catalog — including BPC-157, NAD+, Tesamorelin, and Epitalon — ships with a third-party COA reporting both purity and, where determined, net peptide content, so researchers aren't left inferring the second number from the first.
All products are sold strictly for laboratory and in vitro research use only, and are not intended for human or veterinary use, diagnostic procedures, or any application outside a qualified research setting.